Personal tools

MCL coexpression mm9:140: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 3: Line 3:
|coexpression_dpi_cluster_scores_median=0,0.0473378236136103,0,0.114765798731257,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0177235328243841,0,0,0.170255044926815,0.164001280677683,0,0,0.0847446845832032,0.245535782973247,0.0807968677453011,0.0869754197833955,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0570741246689917,0,0,0,0,0,0,0,0,0,0,0.22710021010079,0,0,0,0,0,0,0,0,0.174463933976285,0,0,0,0,0,0,0,0,0.998572938134105,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.695921474227174,0.335023595090329,0,0,0,0.0797901069290224,0.0872055405749939,0.0756292965920817,0.990157142170656,0.238932143485845,0.302188197538295,0.378887397279725,0.336416607008679,1.07136027950052,0.726136965928552,0.651652708987799,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0326283328848338,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0251839188384021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.06044512522811,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.034489466458534,0,0.181199263188366,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0845301845292944,0,0,0
|coexpression_dpi_cluster_scores_median=0,0.0473378236136103,0,0.114765798731257,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0177235328243841,0,0,0.170255044926815,0.164001280677683,0,0,0.0847446845832032,0.245535782973247,0.0807968677453011,0.0869754197833955,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0570741246689917,0,0,0,0,0,0,0,0,0,0,0.22710021010079,0,0,0,0,0,0,0,0,0.174463933976285,0,0,0,0,0,0,0,0,0.998572938134105,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.695921474227174,0.335023595090329,0,0,0,0.0797901069290224,0.0872055405749939,0.0756292965920817,0.990157142170656,0.238932143485845,0.302188197538295,0.378887397279725,0.336416607008679,1.07136027950052,0.726136965928552,0.651652708987799,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0326283328848338,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0251839188384021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.06044512522811,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.034489466458534,0,0.181199263188366,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0845301845292944,0,0,0
|gostat_on_MCL_coexpression=GO:0009057;macromolecule catabolic process;0.0247987635291779;17448,12380,17384,18293!GO:0006096;glycolysis;0.0247987635291779;17448,18293!GO:0015898;amiloride transport;0.0247987635291779;76507!GO:0016024;CDP-diacylglycerol biosynthetic process;0.0247987635291779;74596!GO:0050164;oxoglutarate dehydrogenase (NADP+) activity;0.0247987635291779;18293!GO:0030303;stromelysin 2 activity;0.0247987635291779;17384!GO:0030161;calpain inhibitor activity;0.0247987635291779;12380!GO:0046341;CDP-diacylglycerol metabolic process;0.0247987635291779;74596!GO:0006007;glucose catabolic process;0.0247987635291779;17448,18293!GO:0046365;monosaccharide catabolic process;0.0247987635291779;17448,18293!GO:0019320;hexose catabolic process;0.0247987635291779;17448,18293!GO:0009056;catabolic process;0.0247987635291779;17448,12380,17384,18293!GO:0046164;alcohol catabolic process;0.0247987635291779;17448,18293!GO:0008654;phospholipid biosynthetic process;0.0247987635291779;13026,74596!GO:0044275;cellular carbohydrate catabolic process;0.0247987635291779;17448,18293!GO:0004605;phosphatidate cytidylyltransferase activity;0.0247987635291779;74596!GO:0045634;regulation of melanocyte differentiation;0.0247987635291779;14672!GO:0042587;glycogen granule;0.0247987635291779;13026!GO:0004105;choline-phosphate cytidylyltransferase activity;0.0247987635291779;13026!GO:0050932;regulation of pigment cell differentiation;0.0247987635291779;14672!GO:0004591;oxoglutarate dehydrogenase (succinyl-transferring) activity;0.0247987635291779;18293!GO:0016052;carbohydrate catabolic process;0.0247987635291779;17448,18293!GO:0046467;membrane lipid biosynthetic process;0.0247987635291779;13026,74596!GO:0048038;quinone binding;0.0304929991876725;76507!GO:0030060;L-malate dehydrogenase activity;0.0304929991876725;17448!GO:0030976;thiamin pyrophosphate binding;0.0304929991876725;18293!GO:0006006;glucose metabolic process;0.0364354278864612;17448,18293!GO:0060158;dopamine receptor, phospholipase C activating pathway;0.0364354278864612;14672!GO:0006651;diacylglycerol biosynthetic process;0.0364354278864612;74596!GO:0016779;nucleotidyltransferase activity;0.0406319751788347;13026,74596!GO:0006108;malate metabolic process;0.0412564231525579;17448!GO:0008131;amine oxidase activity;0.0412564231525579;76507!GO:0006644;phospholipid metabolic process;0.044031454269364;13026,74596!GO:0006656;phosphatidylcholine biosynthetic process;0.0465750754568059;13026!GO:0019318;hexose metabolic process;0.0485965440168064;17448,18293!GO:0046460;neutral lipid biosynthetic process;0.0485965440168064;74596!GO:0016624;oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor;0.0485965440168064;18293!GO:0046463;acylglycerol biosynthetic process;0.0485965440168064;74596!GO:0005996;monosaccharide metabolic process;0.0490593965590794;17448,18293!GO:0016615;malate dehydrogenase activity;0.0490593965590794;17448!GO:0046504;glycerol ether biosynthetic process;0.0490593965590794;74596!GO:0045017;glycerolipid biosynthetic process;0.0490593965590794;74596!GO:0046339;diacylglycerol metabolic process;0.0490593965590794;74596!
|gostat_on_MCL_coexpression=GO:0009057;macromolecule catabolic process;0.0247987635291779;17448,12380,17384,18293!GO:0006096;glycolysis;0.0247987635291779;17448,18293!GO:0015898;amiloride transport;0.0247987635291779;76507!GO:0016024;CDP-diacylglycerol biosynthetic process;0.0247987635291779;74596!GO:0050164;oxoglutarate dehydrogenase (NADP+) activity;0.0247987635291779;18293!GO:0030303;stromelysin 2 activity;0.0247987635291779;17384!GO:0030161;calpain inhibitor activity;0.0247987635291779;12380!GO:0046341;CDP-diacylglycerol metabolic process;0.0247987635291779;74596!GO:0006007;glucose catabolic process;0.0247987635291779;17448,18293!GO:0046365;monosaccharide catabolic process;0.0247987635291779;17448,18293!GO:0019320;hexose catabolic process;0.0247987635291779;17448,18293!GO:0009056;catabolic process;0.0247987635291779;17448,12380,17384,18293!GO:0046164;alcohol catabolic process;0.0247987635291779;17448,18293!GO:0008654;phospholipid biosynthetic process;0.0247987635291779;13026,74596!GO:0044275;cellular carbohydrate catabolic process;0.0247987635291779;17448,18293!GO:0004605;phosphatidate cytidylyltransferase activity;0.0247987635291779;74596!GO:0045634;regulation of melanocyte differentiation;0.0247987635291779;14672!GO:0042587;glycogen granule;0.0247987635291779;13026!GO:0004105;choline-phosphate cytidylyltransferase activity;0.0247987635291779;13026!GO:0050932;regulation of pigment cell differentiation;0.0247987635291779;14672!GO:0004591;oxoglutarate dehydrogenase (succinyl-transferring) activity;0.0247987635291779;18293!GO:0016052;carbohydrate catabolic process;0.0247987635291779;17448,18293!GO:0046467;membrane lipid biosynthetic process;0.0247987635291779;13026,74596!GO:0048038;quinone binding;0.0304929991876725;76507!GO:0030060;L-malate dehydrogenase activity;0.0304929991876725;17448!GO:0030976;thiamin pyrophosphate binding;0.0304929991876725;18293!GO:0006006;glucose metabolic process;0.0364354278864612;17448,18293!GO:0060158;dopamine receptor, phospholipase C activating pathway;0.0364354278864612;14672!GO:0006651;diacylglycerol biosynthetic process;0.0364354278864612;74596!GO:0016779;nucleotidyltransferase activity;0.0406319751788347;13026,74596!GO:0006108;malate metabolic process;0.0412564231525579;17448!GO:0008131;amine oxidase activity;0.0412564231525579;76507!GO:0006644;phospholipid metabolic process;0.044031454269364;13026,74596!GO:0006656;phosphatidylcholine biosynthetic process;0.0465750754568059;13026!GO:0019318;hexose metabolic process;0.0485965440168064;17448,18293!GO:0046460;neutral lipid biosynthetic process;0.0485965440168064;74596!GO:0016624;oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor;0.0485965440168064;18293!GO:0046463;acylglycerol biosynthetic process;0.0485965440168064;74596!GO:0005996;monosaccharide metabolic process;0.0490593965590794;17448,18293!GO:0016615;malate dehydrogenase activity;0.0490593965590794;17448!GO:0046504;glycerol ether biosynthetic process;0.0490593965590794;74596!GO:0045017;glycerolipid biosynthetic process;0.0490593965590794;74596!GO:0046339;diacylglycerol metabolic process;0.0490593965590794;74596!
|ontology_enrichment_celltype=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0000160!3.94e-34!31;UBERON:0005409!9.20e-26!47;UBERON:0002108!6.95e-12!4;UBERON:0000344!7.68e-11!15;UBERON:0001007!1.30e-10!116;UBERON:0001555!1.30e-10!116;UBERON:0007026!1.30e-10!116;UBERON:0004119!2.42e-10!118;UBERON:0000925!2.42e-10!118;UBERON:0006595!2.42e-10!118;UBERON:0000331!5.76e-09!3;UBERON:0002116!5.76e-09!3;UBERON:0001204!5.76e-09!3;UBERON:0001168!5.76e-09!3;UBERON:0004921!9.84e-09!114;UBERON:0004923!5.08e-08!24;UBERON:0001242!3.03e-07!13;UBERON:0000060!3.03e-07!13;UBERON:0001262!3.03e-07!13;UBERON:0004786!3.03e-07!13
}}
}}

Revision as of 16:50, 11 October 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr10:116725466..116725476,-p@chr10:116725466..116725476
-
Mm9::chr10:127798349..127798397,+p@chr10:127798349..127798397
+
Mm9::chr10:80857831..80857846,+p@chr10:80857831..80857846
+
Mm9::chr10:80858998..80859002,+p@chr10:80858998..80859002
+
Mm9::chr10:80993203..80993223,-p@chr10:80993203..80993223
-
Mm9::chr10:80993268..80993292,-p@chr10:80993268..80993292
-
Mm9::chr10:90584691..90584739,-p2@LOC100046151
p2@Slc25a3
Mm9::chr11:105850561..105850570,+p@chr11:105850561..105850570
+
Mm9::chr11:115744245..115744271,+p@chr11:115744245..115744271
+
Mm9::chr11:120915739..120915758,-p@chr11:120915739..120915758
-
Mm9::chr11:120916189..120916224,-p@chr11:120916189..120916224
-
Mm9::chr11:120916370..120916381,-p@chr11:120916370..120916381
-
Mm9::chr11:21465891..21465910,-p@chr11:21465891..21465910
-
Mm9::chr11:6122242..6122286,-p@chr11:6122242..6122286
-
Mm9::chr11:6128416..6128452,-p@chr11:6128416..6128452
-
Mm9::chr11:6129086..6129105,-p@chr11:6129086..6129105
-
Mm9::chr11:6246536..6246561,+p@chr11:6246536..6246561
+
Mm9::chr11:62972318..62972333,+p@chr11:62972318..62972333
+
Mm9::chr11:78776623..78776640,-p@chr11:78776623..78776640
-
Mm9::chr13:54819921..54819933,+p@chr13:54819921..54819933
+
Mm9::chr13:74891788..74891815,-p@chr13:74891788..74891815
-
Mm9::chr15:74709813..74709823,-p@chr15:74709813..74709823
-
Mm9::chr15:75697561..75697570,+p@chr15:75697561..75697570
+
Mm9::chr15:78681407..78681425,-p@chr15:78681407..78681425
-
Mm9::chr15:85062984..85063010,+p@chr15:85062984..85063010
+
Mm9::chr15:85068930..85068959,+p@chr15:85068930..85068959
+
Mm9::chr15:99554264..99554288,+p@chr15:99554264..99554288
+
Mm9::chr16:32471582..32471616,+p@chr16:32471582..32471616
+
Mm9::chr16:32486254..32486261,-p@chr16:32486254..32486261
-
Mm9::chr16:33799053..33799075,+p@chr16:33799053..33799075
+
Mm9::chr16:33818973..33818985,+p@chr16:33818973..33818985
+
Mm9::chr16:56691112..56691125,-p@chr16:56691112..56691125
-
Mm9::chr16:58733883..58733901,+p@chr16:58733883..58733901
+
Mm9::chr17:35482607..35482613,+p@chr17:35482607..35482613
+
Mm9::chr17:37035160..37035171,+p4@Trim31
Mm9::chr17:6959067..6959093,-p@chr17:6959067..6959093
-
Mm9::chr19:40639532..40639548,-p@chr19:40639532..40639548
-
Mm9::chr19:6108680..6108697,+p@chr19:6108680..6108697
+
Mm9::chr1:130215675..130215691,-p@chr1:130215675..130215691
-
Mm9::chr1:130224326..130224332,-p@chr1:130224326..130224332
-
Mm9::chr1:132730972..132730993,+p@chr1:132730972..132730993
+
Mm9::chr1:168095965..168095974,+p@chr1:168095965..168095974
+
Mm9::chr1:173461262..173461279,-p@chr1:173461262..173461279
-
Mm9::chr1:174422311..174422323,+p@chr1:174422311..174422323
+
Mm9::chr1:74478918..74478947,+p@chr1:74478918..74478947
+
Mm9::chr2:121185294..121185305,+p@chr2:121185294..121185305
+
Mm9::chr2:127531221..127531251,-p@chr2:127531221..127531251
-
Mm9::chr2:127531403..127531417,-p@chr2:127531403..127531417
-
Mm9::chr2:70967832..70967858,+p@chr2:70967832..70967858
+
Mm9::chr3:107687704..107687729,+p@chr3:107687704..107687729
+
Mm9::chr3:122996601..122996627,+p@chr3:122996601..122996627
+
Mm9::chr3:137754095..137754119,-p@chr3:137754095..137754119
-
Mm9::chr3:3657068..3657079,+p@chr3:3657068..3657079
+
Mm9::chr3:63135586..63135592,+p@chr3:63135586..63135592
+
Mm9::chr3:72746125..72746128,-p@chr3:72746125..72746128
-
Mm9::chr3:72766054..72766059,-p@chr3:72766054..72766059
-
Mm9::chr4:11737430..11737452,+p@chr4:11737430..11737452
+
Mm9::chr4:117904384..117904399,-p@chr4:117904384..117904399
-
Mm9::chr4:46551261..46551280,-p@chr4:46551261..46551280
-
Mm9::chr5:102243505..102243543,+p@chr5:102243505..102243543
+
Mm9::chr5:136259235..136259279,+p@chr5:136259235..136259279
+
Mm9::chr5:31236245..31236255,-p@chr5:31236245..31236255
-
Mm9::chr5:33454755..33454762,+p@chr5:33454755..33454762
+
Mm9::chr6:29820558..29820602,+p10@Ahcyl2
Mm9::chr6:40606408..40606419,+p@chr6:40606408..40606419
+
Mm9::chr6:48856081..48856092,+p@chr6:48856081..48856092
+
Mm9::chr6:48856094..48856111,+p@chr6:48856094..48856111
+
Mm9::chr6:86600154..86600167,-p@chr6:86600154..86600167
-
Mm9::chr7:148455350..148455374,-p@chr7:148455350..148455374
-
Mm9::chr7:148458990..148459016,-p@chr7:148458990..148459016
-
Mm9::chr7:148542014..148542028,+p@chr7:148542014..148542028
+
Mm9::chr7:148542041..148542053,+p@chr7:148542041..148542053
+
Mm9::chr7:28871365..28871380,+p@chr7:28871365..28871380
+
Mm9::chr7:28878599..28878625,+p@chr7:28878599..28878625
+
Mm9::chr7:29679364..29679380,-p@chr7:29679364..29679380
-
Mm9::chr7:30032141..30032157,-p@chr7:30032141..30032157
-
Mm9::chr7:91300283..91300297,-p@chr7:91300283..91300297
-
Mm9::chr8:109187783..109187801,+p@chr8:109187783..109187801
+
Mm9::chr8:46392160..46392176,-p@chr8:46392160..46392176
-
Mm9::chr9:46050751..46050794,+p@chr9:46050751..46050794
+
Mm9::chr9:7502340..7502345,+p1@Mmp10
Mm9::chr9:98405173..98405185,+p@chr9:98405173..98405185
+


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

GO IDGO nameFDR corrected p-value
GO:0009057macromolecule catabolic process0.0247987635291779
GO:0006096glycolysis0.0247987635291779
GO:0015898amiloride transport0.0247987635291779
GO:0016024CDP-diacylglycerol biosynthetic process0.0247987635291779
GO:0050164oxoglutarate dehydrogenase (NADP+) activity0.0247987635291779
GO:0030303stromelysin 2 activity0.0247987635291779
GO:0030161calpain inhibitor activity0.0247987635291779
GO:0046341CDP-diacylglycerol metabolic process0.0247987635291779
GO:0006007glucose catabolic process0.0247987635291779
GO:0046365monosaccharide catabolic process0.0247987635291779
GO:0019320hexose catabolic process0.0247987635291779
GO:0009056catabolic process0.0247987635291779
GO:0046164alcohol catabolic process0.0247987635291779
GO:0008654phospholipid biosynthetic process0.0247987635291779
GO:0044275cellular carbohydrate catabolic process0.0247987635291779
GO:0004605phosphatidate cytidylyltransferase activity0.0247987635291779
GO:0045634regulation of melanocyte differentiation0.0247987635291779
GO:0042587glycogen granule0.0247987635291779
GO:0004105choline-phosphate cytidylyltransferase activity0.0247987635291779
GO:0050932regulation of pigment cell differentiation0.0247987635291779
GO:0004591oxoglutarate dehydrogenase (succinyl-transferring) activity0.0247987635291779
GO:0016052carbohydrate catabolic process0.0247987635291779
GO:0046467membrane lipid biosynthetic process0.0247987635291779
GO:0048038quinone binding0.0304929991876725
GO:0030060L-malate dehydrogenase activity0.0304929991876725
GO:0030976thiamin pyrophosphate binding0.0304929991876725
GO:0006006glucose metabolic process0.0364354278864612
GO:0060158dopamine receptor, phospholipase C activating pathway0.0364354278864612
GO:0006651diacylglycerol biosynthetic process0.0364354278864612
GO:0016779nucleotidyltransferase activity0.0406319751788347
GO:0006108malate metabolic process0.0412564231525579
GO:0008131amine oxidase activity0.0412564231525579
GO:0006644phospholipid metabolic process0.044031454269364
GO:0006656phosphatidylcholine biosynthetic process0.0465750754568059
GO:0019318hexose metabolic process0.0485965440168064
GO:0046460neutral lipid biosynthetic process0.0485965440168064
GO:0016624oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor0.0485965440168064
GO:0046463acylglycerol biosynthetic process0.0485965440168064
GO:0005996monosaccharide metabolic process0.0490593965590794
GO:0016615malate dehydrogenase activity0.0490593965590794
GO:0046504glycerol ether biosynthetic process0.0490593965590794
GO:0045017glycerolipid biosynthetic process0.0490593965590794
GO:0046339diacylglycerol metabolic process0.0490593965590794



Relative expression of the co-expression cluster over median <br>Analyst:




Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br><br>

Uber Anatomy
Ontology termp-valuen
intestine3.94e-3431
gastrointestinal system9.20e-2647
small intestine6.95e-124
mucosa7.68e-1115
digestive system1.30e-10116
digestive tract1.30e-10116
primitive gut1.30e-10116
endoderm-derived structure2.42e-10118
endoderm2.42e-10118
presumptive endoderm2.42e-10118
ileal mucosa5.76e-093
ileum5.76e-093
mucosa of small intestine5.76e-093
wall of small intestine5.76e-093
subdivision of digestive tract9.84e-09114
organ component layer5.08e-0824
intestinal mucosa3.03e-0713
anatomical wall3.03e-0713
wall of intestine3.03e-0713
gastrointestinal system mucosa3.03e-0713


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}

Retrieved from "http://f5-webapp4.gsc.riken.jp/resource_browser/index.php?title=MCL_coexpression_mm9:140&oldid=2153510"